PMN ProMIS Neurosciences, Inc.

NASDAQ
$3.48

ProMIS Neurosciences, Inc. (PMN) is confirmed to report earnings on November 12, 2026, after the market close. The consensus earnings estimate is a loss of $1.24 per share.

ProMIS Neurosciences Beat Consensus Estimates
Thursday, November 12, 2026 · 4:05 PM ET
Earnings Date
4th Quarter, Dec 2026
Nov 12
Thursday · 4:00 PM ET
Earnings Whisper
-
vs ($1.24)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $5.03

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About ProMIS Neurosciences, Inc.

ProMIS Neurosciences is a clinical-stage biotechnology company committed to the discovery and development of therapeutic antibodies and vaccines selective for toxic oligomers associated with the development and progression of neurodegenerative and other misfolded protein diseases.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.